Position in PBYI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,104,564
+$870,295 QoQ
Shares Held
382,807
+9.5% QoQ
Ownership
0.742%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#24
of 160 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $30,619,322 across 13 Biotechnology names. PBYI ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
254,993 | $13,874,169 | |
| 2 | RIGL |
Rigel Pharmaceuticals Inc
|
112,672 | $4,407,728 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
This page
|
382,807 | $3,104,564 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
191,904 | $2,751,903 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,645 | $2,565,125 | |
| 6 | AGEN |
Agenus Inc
|
418,581 | $1,280,857 | |
| 7 | INCY |
Incyte Corp
|
8,654 | $981,017 | |
| 8 | ARVN |
Arvinas, Inc.
|
59,331 | $493,040 |
All Filings in PBYI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,104,564 | 382,807 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,234,269 | 349,651 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,693,005 | 452,606 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,403,337 | 452,606 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,552,438 | 452,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,339,713 | 452,606 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,380,448 | 452,606 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,154,145 | 452,606 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,475,495 | 452,606 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,606,280 | 491,751 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,331,960 | 538,559 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,416,410 | 538,559 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,982,200 | 561,530 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,735,127 | 561,530 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,375,271 | 561,530 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,352,890 | 570,840 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,195,067 | 419,322 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,008,645 | 350,224 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,256,678 | 413,381 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,899,980 | 413,692 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,109,895 | 447,701 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,166,769 | 428,680 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $564,577 | 55,027 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $555,222 | 55,027 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $659,447 | 63,226 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||